Reading SRXH? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SRXH free→Reading SRXH? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SRXH free→QuarterlyIQ Insights · SRXH
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. Private Placement Securities Purchase Agreement On March 16, 2026, SRx Health Solutions, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 10,000 shares of the Company’s Series B convertible preferred stock, par value $0.001 per share (the “Series B Preferred Stock”) and…
Unregistered Sales of Equity Securities. The information provided in
Entry into a Material Definitive Agreement. As previously disclosed, on July 7, 2025, the Company entered into a Securities Purchase Agreement (the “Note Purchase Agreement”) by and among the Company and certain accredited investors named therein (the “Note Investors”), pursuant to which the Company issued and sold to the Note Investors (i) a new series of senior secured convertible notes (the “Notes”) with an aggregate original principal amount of $7,650,000, subject to an original issue dis…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 18, 2026, SRx Health Solutions, Inc. (the “Company”) received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the “Company Guide”). The Letter relates to the issuance of approximately 7.5 million shares…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On January 6, 2026, SRx Health Solutions, Inc. (the “Company”), received a notice from the NYSE American (“NYSE”), that NYSE has accepted the Company’s plan to regain compliance with Sections 1003(a)(i) and (ii) of the NYSE American Company Guide. As previously disclosed, NYSE notified the Company on October 14, 2025, that the Company had fallen below the NYSE’s continued listing standard requ…
Entry into a Material Definitive Agreement. On December 16, 2025, SRx Health Solutions, Inc. (the “Company”) entered into a Share Exchange and Asset Transfer Agreement (the “Transfer Agreement”), as unanimously approved by the Board, by and among the Company, EMJ Crypto Technologies Inc., a corporation organized under the laws of Ontario, Canada (“EMJC”), CCC Crypto Corp., a Delaware corporation (“DelawareCo”), and the transferors named therein (the “Transferors”). Upon the terms and subject…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Sammy Dorf as a Director On November 10, 2025, the Board of Directors (the “Board”) of SRx Health Solutions, Inc., a Delaware corporation (the “Company”) appointed Sammy Dorf, Esq. as a director of the Company, effective immediately, to serve in such capacity until a successor has been elected and qualified, or until his resignation…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information provided in
Entry into a Material Definitive Agreement. Private Placement Securities Purchase Agreement On October 27, 2025, SRx Health Solutions, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 38,070 shares of the Company’s Series A convertible preferred stock, par value $0.001 per share (the “Series A Preferred Stock”) an…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On October 31, 2025, the Company accepted the voluntary resignation of each of Lionel F. Conacher and David Allen White from the Company’s Board of Directors, effective immediately. Neither resignation is the result of any dispute or disagreement with the Company on any matters relating to the Company’s financial statements, internal controls, operations, policies, or practices. Following s…
Unregistered Sales of Equity Securities. The information provided in
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On October 14, 2025, SRx Health Solutions, Inc, a Delaware corporation. (the “Company”) received a written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (“Section 1003(a)(ii)”). Section 1003(a)(ii) require…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Joshua A. Epstein as a Director On October 1, 2025, the Board of Directors (the “Board”) of SRx Health Solutions, Inc., a Delaware corporation (the “Company”) appointed Joshua A. Epstein, as a director of the Company, effective immediately, to serve in such capacity until a successor has been elected and qualified, or until his resig…
Change in Registrant’s Certifying Accountant. On September 15, 2025, SRx Health Solutions, Inc. (formerly known as Better Choice Company, Inc.) (the “Company”), notified CBIZ CPAs P.C. (“CBIZ”) that it was being dismissed as the Company’s independent registered public accounting firm. On the same date, the Board of Directors of the Company, upon the recommendation of the Audit Committee, approved the dismissal of CBIZ, and approved and ratified the engagement of Davidson and Company LLP (“Dav…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On August 13, 2025, the Company accepted the voluntary resignation of Adesh Vora from the Company’s Board of Directors, effective immediately. Mr. Vora’s resignation is the result of SRx Canada’s previously announced proceedings in Canada under the federal Companies’ Creditors Arrangement Act.
Entry into a Material Definitive Agreement On August 14, 2025, SRx Health Solutions, Inc., a Delaware corporation (the “Company”), announced that it has canceled approximately 18,839,332 million shares of its capital stock pursuant to a Settlement, Share Forfeiture and Mutual Release Agreement (the “Settlement Agreement”) with certain of the founders and officers of SRx Health Solutions (Canada), Inc. (“SRx Canada”), a corporation organized under the laws of Ontario, Canada and a wholly-owned…
Other Events. CCAA Proceedings and Debtor-in-Possession Financing On August 12, 2025, SRx Health Solutions, Inc., a Delaware corporation (the “Company”) announced that SRx Health Solutions (Canada), Inc., its wholly owned subsidiary (“SRx Canada”) sought, and later announced that SRx Canada had obtained, an Initial Order (the “Initial Order”) in Canada under the federal Companies’ Creditors Arrangement Act (the “CCAA” and SRx Canada’s proceedings thereunder, the “CCAA Proceedings”) from the O…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. Resignation and replacement of Chief Executive Officer On July 8, 2025, SRx Health Solutions, Inc. (the “ Company ”) accepted the voluntary resignation of Adesh Vora as the Chief Executive Officer of the Company. His resignation is not the result of any dispute or disagreement with the Company on any matters relating to the Company’s financial statements, internal controls, operations, poli…
Based in part upon the representations of the Lead Investor and the other investors named therein, as applicable, in the ELOC Purchase Agreement and the Note Purchase Agreement, the offer and sale of the Common Shares by the Company to the Lead Investor and the other investors named therein, as applicable, under ELOC Purchase Agreement and the Note Purchase Agreement is exempt from the registration requirements of the Securities Act of 1933 (the “ Securities Act ”), pursuant to the exemptions…
Entry into a Material Definitive Agreement. Equity Line of Credit On July 7, 2025, SRx Health Solutions, Inc. (the “ Company ”) and an investor (the “ Lead Investor ”), entered into a common share purchase agreement (the “ ELOC Purchase Agreement ”), which provides that subject to the terms and conditions set forth therein, the Company may sell to the Investor up to the lesser of (i) $50,000,000 of the Company’s common shares, no par value (the “ Common Share ”) and (ii) the Exchange Cap (as…
Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. On June 10, 2025, SRx Health Solutions, Inc. (the “ Company ”) accepted the voluntary resignation of Davender Sohi as the President of the Company, effective immediately. His resignation is not the result of any dispute or disagreement with the Company on any matters relating to the Company’s financial statements, internal controls, operations, policies, or practices. On June 11, 2025, the…
Changes in Registrant’s Certifying Accountant. Based on information provided by Marcum LLP (“Marcum”), the independent registered public accounting firm of SRx Health Solutions, Inc. (formerly known as Better Choice Company Inc.) (the “Company”), CBIZ CPAs P.C. (“CBIZ CPAs”) acquired the attest business of Marcum, effective November 1, 2024. Marcum continued to serve as the Company’s independent registered public accounting firm through April 23, 2025. On April 23, 2025, Marcum resigned as th…
Entry into a Material Definitive Agreement Addendum to Arrangement Agreement On April 16, 2025, Better Choice Company Inc., a Delaware corporation (the “Company”), entered into an Addendum (the “Addendum”) to its previously announced Arrangement Agreement (the “Arrangement Agreement”) with SRx Health Solutions Inc., a corporation organized under the laws of the Province of Ontario (“SRx”), 1000994476 Ontario Inc., an indirect wholly-owned subsidiary of the Company and a corporation existing u…
Results of Operations and Financial Condition On March 27, 2025, Better Choice Company Inc., a Delaware corporation (“the Company”), announced its financial results for the fourth quarter and year ended December 31, 2024. A copy of the press release is attached hereto as Exhibit 99.1. Cautionary Note Regarding Forward-Looking Statements This Current Report on Form 8-K contains statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Refor…
Importance-ranked changes since the prior daily snapshot.
Signal changed from 'cautious' to 'restrictive'.
Valuation label changed from 'fair' to 'full'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.